Internal analgesic warning label size would be reduced by 40% under NDMA proposal.
This article was originally published in The Tan Sheet
Executive Summary
OTC INTERNAL ANALGESICS WARNING SIZE WOULD BE REDUCED BY 40%, from 52 to 30 words, under a proposal presented to FDA by the Non-prescription Drug Manufacturers Association at an Aug. 17 "OTC feedback" meeting on label reform. The meeting was the first in a series between FDA and NDMA that will focus on OTC labeling issues.